Searched for
GENERIC OXALIPLATIN PRODUCTS
- Sun Pharma Q1 net zooms 244 pc to Rs 564.32 crSun Pharmaceutical Industries today reported a 244.43 per cent jump in net profit at Rs 564.32 crore for the quarter ended June.28 Jul, 2010, 04.50 PM IST
- Sun Pharma suffers second setback in US patent rowSun Pharmaceutical Industries suffered its second setback in the US litigation within four days after a New Jersey district court decided t...27 Apr, 2010, 01.55 AM IST
- US court bans Sun from selling Eloxatin: Sanofi AventisFrench drug maker Sanofi Aventis SA on Friday said a New Jersey US district court ordered Sun Pharma to stop selling its generic version of...23 Apr, 2010, 10.58 PM IST
- Sun's EPS may take a knock if it stops cancer drug saleThe stock of Sun Pharma fell for a fourth day in a row, as investors are worried about the company's legal tussle with Sanofi-Aventis over ...10 Apr, 2010, 01.05 AM IST
- Sanofi to eclipse Sun’s Eloxatin planFrance’s largest pharma company, Sanofi-Aventis, is suing India’s Sun Pharmaceuticals and Hospira’s Mayne Pharma to prevent the latter from...26 Jul, 2007, 02.42 AM IST
- US firm files suit against Dabur PharmaUS-based Sanofi-Aventis LLC has filed a lawsuit against Dabur Pharma and its UK arm - Dabur Oncology Pte, over a USFDA filing seeking appro...22 Jun, 2007, 10.00 PM IST
Load More- Sun Pharma Q1 net zooms 244 pc to Rs 564.32 cr
